0.8-100ng/ML CK-MB Test Kit Immunofluorescence Chromatography

0.8~100ng/ML Creatine Kinase Isoenzyme Detection Reagent(CK-MB) (Immunofluorescence Chromatography) Performance Index

CK-MB Overview

Creatine kinase isoenzyme (CK-MB) is an enzyme system widely present in human striated muscle. When striated muscle such as myocardium and skeletal muscle is damaged, creatine kinase isoenzyme will be released into the blood, starting in 4-6 hours Elevated, the peak time is 24 hours, and the recovery time is 48-72 hours.

CK-MB performance index

CK-MB Clinical significance

• Early diagnosis of AMI and risk stratification
• The most valuable marker of MI without ST-segment elevation

CK-MB Clinical value

The isoenzyme of creatine kinase is of great significance in clinical diagnosis. When various diseases including muscle atrophy and myocardial infarction occur, the level of creatine kinase in human serum is rapidly improved. It is believed that it is more reliable to measure the activity of creatine kinase in the diagnosis of myocardial infarction than ECG. In myocardial infarction, creatine kinase increased within 6 hours, peaked 24 hours, and recovered to normal within 3-4 days. CK MB, the isoenzyme of creatine kinase, has the highest specificity in diagnosis. Creatine kinase has attracted more and more attention and in-depth research because of its important physiological function and clinical application value.

CK-MB Normal value

1. Electrophoresis: CK-MB < 0.05 (CK-MB < 5%), CK-MM > 0.94 ~ 0.96 (CK-MM > 94% ~ 96%), CK-BB no or trace (CK-BB no or trace)
2. Enzyme rate method (37 ℃) CK-MB: 0 ~ 18u / L, CK-MM: 0 ~ 18u / L, CK-BB: 0U / L.

Application Department

Cardiology, emergency, laboratory, pediatrics, hematology, oncology, Nephrology, surgery, etc

CK-MB Clinical comparison

MYO Clinical Comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.